Singapore markets open in 6 hours 3 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,300.64 +53.96 (+1.03%) Dow
39,837.07 +278.96 (+0.71%) Nasdaq
16,728.51 +217.33 (+1.32%) Bitcoin USD
65,492.41 +4,103.77 (+6.68%) CMC Crypto 200
1,381.98 +114.04 (+9.00%)
Sedana Medical AB (publ) (SEDANA.ST)
Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
At close: 05:29PM CEST
| Previous close | 23.20 |
| Open | 23.20 |
| Bid | 23.30 x 0 |
| Ask | 23.40 x 0 |
| Day's range | 22.65 - 23.90 |
| 52-week range | 13.88 - 34.50 |
| Volume | |
| Avg. volume | 286,607 |
| Market cap | 2.32B |
| Beta (5Y monthly) | 0.16 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.23 |
| Earnings date | 23 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 43.00 |
PR NewswireSedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235 randomized patients remaining. The company anticipates topline results from both trials in the second half of 2024, with a planned New Drug Application (NDA) submission in the first quarter of 2025.
© 2024 Yahoo. All rights reserved.